Predictive modeling has become an essential methodological framework in modern healthcare, supporting clinical decision-making across diagnosis, prognosis, and treatment planning. Advances in artificial intelligence and machine learning have expanded the scope of predictive models, enabling the integration of heterogeneous clinical, biological, imaging, and nonclinical data. This article provides a comprehensive and methodologically grounded review of predictive modeling in healthcare, emphasizing its theoretical foundations, modeling strategies, validation practices, and real-world clinical applications. Drawing on established and recent literature, the manuscript synthesizes developments in predictive modeling for cardiovascular disease risk assessment, cancer therapeutic response prediction, surgical outcome estimation, and risk stratification using physiological signals. Particular attention is given to the distinction between diagnostic and prognostic modeling, the role of nonclinical features, and the implications of model interpretability and generalizability. The Methods section outlines common data preprocessing pipelines, feature selection strategies, and modeling techniques, including traditional statistical models and machine learning approaches. The Results section synthesizes reported performance trends and comparative findings from prior studies, while the Discussion critically examines methodological limitations, ethical considerations, and future research directions. Overall, this work aims to serve as a structured reference for researchers and clinicians seeking to design, evaluate, or interpret predictive models in healthcare, while highlighting unresolved challenges related to data quality, bias, and clinical integration.

Disorders of the lymphatic system represent a complex and heterogeneous group of conditions that range from congenital lymphatic dysplasias to acquired inflammatory and infectious lymph node diseases. Despite its central role in tissue fluid balance, immune surveillance, and lipid transport, the lymphatic system has historically received less investigative attention than the blood vascular system. This imbalance has contributed to diagnostic delays, incomplete classification frameworks, and suboptimal clinical management of lymphatic disorders. The present review integrates anatomical, developmental, molecular, and pathological perspectives to provide a comprehensive understanding of primary lymphatic disorders and peripheral lymph node pathology, with particular emphasis on cervical and peripheral lymphadenopathy.

Drawing on classical anatomical descriptions, contemporary molecular insights into lymphangiogenesis, and clinicopathological correlations from cytological and histopathological studies, this article synthesizes evidence across disciplines. The discussion highlights advances in the classification of primary lymphatic dysplasias, evolving concepts of lymphangiogenic signaling pathways, and the diagnostic value of fine-needle aspiration cytology in infectious and non-infectious lymphadenopathies. Tubercular lymphadenitis, a major contributor to peripheral lymph node enlargement in developing regions, is examined in detail to illustrate the intersection between lymphatic biology and infectious disease pathology.

By emphasizing structure–function relationships and integrating traditional pathology with emerging molecular frameworks, this review aims to bridge existing gaps between basic science and clinical practice. A clearer conceptualization of lymphatic disorders is essential for improving diagnostic accuracy, guiding therapeutic decision-making, and informing future research directions in lymphatic biology and disease.